Latest filings (excl ownership)
No filings
Latest ownership filings
4
Tempest Therapeutics, Inc.
12 Aug 24
4
Contineum Therapeutics, Inc.
11 Apr 24
3
Contineum Therapeutics, Inc.
4 Apr 24
4
Oyster Point Pharma, Inc.
4 Jan 23
4
Tempest Therapeutics, Inc.
3 May 22
SC 13G
MINERVA SURGICAL INC
11 Feb 22
4
Oyster Point Pharma, Inc.
7 Jan 22
4
Oyster Point Pharma, Inc.
23 Dec 21
4
Oyster Point Pharma, Inc.
20 Oct 21
3
Tempest Therapeutics, Inc.
6 Jul 21
4
Oyster Point Pharma, Inc.
14 May 21
4
Oyster Point Pharma, Inc.
30 Mar 21
4
Oyster Point Pharma, Inc.
19 Feb 21
4
Inari Medical, Inc.
19 Nov 20
SC 13D/A
CRISPR Therapeutics AG
18 Sep 20
4
IVERIC bio, Inc.
23 Jun 20
4
Inari Medical, Inc.
27 May 20
3
Inari Medical, Inc.
21 May 20
4
Oyster Point Pharma, Inc.
4 Nov 19
3
Oyster Point Pharma, Inc.
30 Oct 19
SC 13D/A
CRISPR Therapeutics AG
28 Jun 19
4
Ophthotech Corp.
16 Jan 19
3
Ophthotech Corp.
9 Nov 18
4
CRISPR Therapeutics AG
24 Apr 18
SC 13D/A
CRISPR Therapeutics AG
15 Sep 17
4
CRISPR Therapeutics AG
7 Sep 17
4/A
CRISPR Therapeutics AG
23 Dec 16
SC 13D
CRISPR Therapeutics AG
3 Nov 16
4
CRISPR Therapeutics AG
26 Oct 16
3
CRISPR Therapeutics AG
18 Oct 16
3
Audentes Therapeutics, Inc.
19 Jul 16
3
Capital IV (Switzerland) GmbH Versant
18 May 16